These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 24297797)

  • 21. Relationship of hemoglobin A1C and mortality in heart failure patients with diabetes.
    Aguilar D; Bozkurt B; Ramasubbu K; Deswal A
    J Am Coll Cardiol; 2009 Jul; 54(5):422-8. PubMed ID: 19628117
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of HbA1c variability on long-term outcomes in patients with heart failure and type 2 diabetes mellitus.
    Gu J; Pan JA; Fan YQ; Zhang HL; Zhang JF; Wang CQ
    Cardiovasc Diabetol; 2018 Jun; 17(1):96. PubMed ID: 29960591
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Linagliptin Effects on Heart Failure and Related Outcomes in Individuals With Type 2 Diabetes Mellitus at High Cardiovascular and Renal Risk in CARMELINA.
    McGuire DK; Alexander JH; Johansen OE; Perkovic V; Rosenstock J; Cooper ME; Wanner C; Kahn SE; Toto RD; Zinman B; Baanstra D; Pfarr E; Schnaidt S; Meinicke T; George JT; von Eynatten M; Marx N;
    Circulation; 2019 Jan; 139(3):351-361. PubMed ID: 30586723
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Both high and low HbA1c predict incident heart failure in type 2 diabetes mellitus.
    Parry HM; Deshmukh H; Levin D; Van Zuydam N; Elder DH; Morris AD; Struthers AD; Palmer CN; Doney AS; Lang CC
    Circ Heart Fail; 2015 Mar; 8(2):236-42. PubMed ID: 25561089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aldosterone, Renin, and Diabetes Mellitus in African Americans: The Jackson Heart Study.
    Joseph JJ; Echouffo-Tcheugui JB; Kalyani RR; Yeh HC; Bertoni AG; Effoe VS; Casanova R; Sims M; Correa A; Wu WC; Wand GS; Golden SH
    J Clin Endocrinol Metab; 2016 Apr; 101(4):1770-8. PubMed ID: 26908112
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gout is associated with an increased risk for incident heart failure among older adults: the REasons for Geographic And Racial Differences in Stroke (REGARDS) cohort study.
    Colantonio LD; Saag KG; Singh JA; Chen L; Reynolds RJ; Gaffo A; Plante TB; Curtis JR; Bridges SL; Levitan EB; Chaudhary NS; Howard G; Safford MM; Muntner P; Irvin MR
    Arthritis Res Ther; 2020 Apr; 22(1):86. PubMed ID: 32299504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.
    Wang Y; Katzmarzyk PT; Horswell R; Zhao W; Li W; Johnson J; Ryan DH; Hu G
    Diabet Med; 2014 Oct; 31(10):1230-6. PubMed ID: 24750373
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of fasting glucose with lifetime risk of incident heart failure: the Lifetime Risk Pooling Project.
    Sinha A; Ning H; Ahmad FS; Bancks MP; Carnethon MR; O'Brien MJ; Allen NB; Wilkins JT; Lloyd-Jones DM; Khan SS
    Cardiovasc Diabetol; 2021 Mar; 20(1):66. PubMed ID: 33752676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dietary Patterns and Incident Heart Failure in U.S. Adults Without Known Coronary Disease.
    Lara KM; Levitan EB; Gutierrez OM; Shikany JM; Safford MM; Judd SE; Rosenson RS
    J Am Coll Cardiol; 2019 Apr; 73(16):2036-2045. PubMed ID: 31023426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial.
    Pandey A; Patel KV; Bahnson JL; Gaussoin SA; Martin CK; Balasubramanyam A; Johnson KC; McGuire DK; Bertoni AG; Kitzman D; Berry JD;
    Circulation; 2020 Apr; 141(16):1295-1306. PubMed ID: 32134326
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incidence of type 2 diabetes in pre-diabetic Japanese individuals categorized by HbA1c levels: a historical cohort study.
    Kawahara T; Imawatari R; Kawahara C; Inazu T; Suzuki G
    PLoS One; 2015; 10(4):e0122698. PubMed ID: 25853519
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differing effects of metformin on glycemic control by race-ethnicity.
    Williams LK; Padhukasahasram B; Ahmedani BK; Peterson EL; Wells KE; González Burchard E; Lanfear DE
    J Clin Endocrinol Metab; 2014 Sep; 99(9):3160-8. PubMed ID: 24921653
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risks of diabetic nephropathy with variation in hemoglobin A1c and fasting plasma glucose.
    Lin CC; Chen CC; Chen FN; Li CI; Liu CS; Lin WY; Yang SY; Lee CC; Li TC
    Am J Med; 2013 Nov; 126(11):1017.e1-10. PubMed ID: 23993260
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HbA
    Metcalf PA; Kyle C; Kenealy T; Jackson RT
    J Diabetes Complications; 2017 May; 31(5):814-823. PubMed ID: 28319002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circulating Vascular Cell Adhesion Molecule-1 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis (MESA).
    Patel RB; Colangelo LA; Bielinski SJ; Larson NB; Ding J; Allen NB; Michos ED; Shah SJ; Lloyd-Jones DM
    J Am Heart Assoc; 2020 Nov; 9(22):e019390. PubMed ID: 33161805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microvascular Disease and Incident Heart Failure Among Individuals With Type 2 Diabetes Mellitus.
    Kaze AD; Santhanam P; Erqou S; Ahima RS; Bertoni A; Echouffo-Tcheugui JB
    J Am Heart Assoc; 2021 Jun; 10(12):e018998. PubMed ID: 34107742
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Dapagliflozin And Prevention of Adverse-outcomes in Heart Failure (DAPA-HF) trial: baseline characteristics.
    McMurray JJV; DeMets DL; Inzucchi SE; Køber L; Kosiborod MN; Langkilde AM; Martinez FA; Bengtsson O; Ponikowski P; Sabatine MS; Sjöstrand M; Solomon SD;
    Eur J Heart Fail; 2019 Nov; 21(11):1402-1411. PubMed ID: 31309699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MR-proANP and incident cardiovascular disease in patients with type 2 diabetes with and without heart failure with preserved ejection fraction.
    Jensen J; Schou M; Kistorp C; Faber J; Hansen TW; Jensen MT; Andersen HU; Rossing P; Vilsbøll T; Jørgensen PG
    Cardiovasc Diabetol; 2020 Oct; 19(1):180. PubMed ID: 33066783
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of Prediabetes and Undiagnosed Diabetes in Patients with HFpEF and HFrEF and Associated Clinical Outcomes.
    Kristensen SL; Jhund PS; Lee MMY; Køber L; Solomon SD; Granger CB; Yusuf S; Pfeffer MA; Swedberg K; McMurray JJV;
    Cardiovasc Drugs Ther; 2017 Dec; 31(5-6):545-549. PubMed ID: 28948430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Racial disparities in diabetic complications in an underinsured population.
    Wang Y; Katzmarzyk PT; Horswell R; Li W; Xiao K; Besse J; Xie W; Johnson J; Heymsfield S; Ryan DH; Hu G
    J Clin Endocrinol Metab; 2012 Dec; 97(12):4446-53. PubMed ID: 22977274
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.